LCAP 8-K
MSP Recovery, Inc. (MSPR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
|
|
|||
|
||||
(Address of principal executive offices) |
|
(Zip Code) |
||
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement.
Yorkville Floor Price Reduction
On October 28, 2025, the MSP Recovery, Inc. (the “Company”) and YA II PN, Ltd. (“Yorkville”) reached an agreement to reduce the Floor Price under the Standby Equity Purchase Agreement dated November 14, 2023, as amended (the “Yorkville SEPA”) and the convertible promissory notes (“Convertible Promissory Notes”) issued from time to time thereunder, from $1.00 to $0.50.
Nomura Amended and Restated Promissory Note
As previously disclosed, the Company entered into a Promissory Note (as amended, the “Nomura Note”) with Nomura Securities International, Inc. (“Nomura”) on May 27, 2022.
On October 24, 2025, the Company further amended and restated the Nomura Note to: (i) reflect the current principal amount outstanding of approximately $35.4 million, and (ii) to include a limited waiver of the Company’s obligation to pay promissory note obligations using the proceeds from Convertible Notes issued pursuant to the Second Supplemental Agreement to the Yorkville SEPA dated October 10, 2025, up to an aggregate total of $3.0 million of such proceeds that would otherwise be paid to Nomura; provided that such proceeds be used solely to fund the operations of the Company.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
As previously disclosed, the Company entered into the Yorkville SEPA, pursuant to which the Company has the right to sell to Yorkville up to $250 million of its shares of common stock, subject to certain limitations and conditions set forth in the Yorkville SEPA, from time to time during the term of the Yorkville SEPA. Sales of the shares of common stock to Yorkville under the Yorkville SEPA, and the timing of any such sales, are at the Company’s option, and the Company is under no obligation to sell any shares of common stock to Yorkville under the Yorkville SEPA except in connection with notices that may be submitted by Yorkville, in certain circumstances as described below.
In connection with the Yorkville SEPA, and subject to the conditions set forth therein, Yorkville agreed to advance capital to the Company in the form of Convertible Promissory Notes. On October 10, 2025, in connection with the Yorkville SEPA, and subject to the terms and conditions set forth therein, the Company and Yorkville entered into a second supplemental agreement to the Yorkville SEPA (the “Second Supplemental Agreement”), whereby Yorkville agreed to advance to the Company, in the form of Convertible Promissory Notes, additional funding of up to $3.0 million, from time to time in such amounts as the Company and Yorkville may mutually agree, and subject to the satisfaction of conditions precedent set forth therein. Advances pursuant to the Second Supplemental Agreement are subject to a 10% original issue discount, and may be issued in increments such that the net principal increase incurred by such advance under the Second Supplemental Agreement to the aggregate principal amount of all Convertible Promissory Notes then outstanding does not exceed $1.0 million.
On October 28, 2025, Yorkville agreed to make an advance under the Second Supplemental Agreement pursuant to a Convertible Promissory Note issued by the Company to Yorkville for the principal amount of $0.50 million, on terms substantially the same as the previous Convertible Promissory Notes, issued pursuant to the Yorkville SEPA, which will result in net proceeds to the Company of $0.45 million.
Yorkville may convert the Convertible Notes into shares of the Company’s common stock at a conversion price equal to the lower of the Fixed Price (as defined in each Convertible Note) or 95% of the lowest daily VWAP during the five consecutive trading days immediately preceding the date of the conversion (the “Conversion Price”), which in no event may the Conversion Price be lower than the Floor Price of $0.50, provided that the number of shares issued does not cause Yorkville to exceed the 9.99% ownership limitation.
In addition, Yorkville, in its sole discretion and providing that there is a balance remaining outstanding under the Convertible Promissory Notes, may deliver a notice under the Yorkville SEPA requiring the issuance and sale of shares of common stock to Yorkville at the Conversion Price in consideration of an offset of the Convertible Promissory Notes (“Yorkville Advance”). Yorkville, in its sole discretion, may select the amount of any Yorkville Advance, provided that the number of shares issued does not cause Yorkville to exceed the 9.99% ownership limitation or the amount of shares of common stock that are registered. As a result of a Yorkville Advance, the amounts payable under the Convertible Promissory Notes will be offset by such amount subject to each Yorkville Advance.
This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares
of common stock, nor shall there be any sale of shares of common stock in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On April 24, 2025, MSP Recovery, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ deficit of $128.4 million, as reported in the Company’s Form 10-K for the year ended December 31, 2024, was below the required minimum of $2.5 million, and because, as of April 24, 2025, the Company did not meet the alternative compliance standards, relating to the market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.
The Company had 45 calendar days from April 24, 2025, or through Monday, June 9, 2025, to submit a plan to regain compliance with Listing Rule 5550(b)(1). The Company submitted its plan on June 5, 2025, and was granted an extension of up to 180 days, or through Tuesday, October 21, 2025, to regain compliance.
On October 22, 2025, the Company received a Staff Delisting Determination (the “Delisting Notification”), notifying the Company that trading of its common stock will be suspended from the Nasdaq Capital Market at the opening of business on October 31, 2025, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq.
Pursuant to the Delisting Notification, the Company has until 4:00 p.m. Eastern Time on October 29, 2025 to submit a written request for a review of the Delisting Notification by a Hearings Panel (the “Panel”). A hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. The Company intends to timely request a review of the Delisting Notification by the Panel.
There can be no assurance that the Panel will grant the Company’s request for continued listing on the Nasdaq Capital Market. If the Company’s Common Stock ceases to be listed for trading on the Nasdaq Capital Market, the Company expects that its Common Stock would continue to trade on the OTCQB Venture Market of the OTC Markets Group.
Item 3.02 Unregistered Sales of Equity Securities.
The information set forth in Item 2.03 of this Current Report on Form 8-K is incorporated herein by reference.
In the Yorkville SEPA, Yorkville represented to the Company, among other things, that it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act). The securities referred to in this Current Report on Form 8-K are being issued and sold by the Company to Yorkville in reliance upon the exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act.
Cautionary Note Regarding Forward-Looking Statements
Certain statements made herein are not historical facts but may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended, and the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “agree,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements involve risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although the Company believes that it has a reasonable basis for each forward-looking statement contained in this Current Report, the Company cautions that these statements are based on a combination of facts and factors currently known by it and its projections of the future, about which it cannot be certain. Forward-looking statements in this Current Report include, but are not limited to, statements regarding the Company’s ability to maintain or regain compliance with Nasdaq’s continued listing standards, and its ability to qualify for listing on the OTCQB Venture Market. These forward-looking statements are based on management’s current beliefs, expectations, and assumptions, and are subject to risks and uncertainties. These risks and uncertainties include, among other things,
the Company’s ability to successfully appeal the Staff’s Delisting Notification, and the Company’s ability to be listed on the OTCQB Venture Market if its common shares are delisted from Nasdaq, and other risks and uncertainties described in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2025, and subsequent Quarterly Reports on Form 10-Q, and other factors detailed from time to time in the Company’s filings with the SEC. The Company undertakes no obligation to revise or update publicly any forward-looking statements.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number |
|
Description |
10.1 |
|
|
10.2 |
|
|
10.3 |
|
|
10.4 |
|
Yorkville Second Supplemental Agreement dated October 10, 2025 |
10.5 |
|
|
104 |
|
Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
MSP RECOVERY, INC. |
||
Dated: October 28, 2025 |
|
|
||||
|
|
|
|
|||
|
|
|
|
By: |
|
/s/ Francisco Rivas-Vasquez |
|
|
|
|
Name: |
|
Francisco Rivas-Vasquez |
|
|
|
|
Title: |
|
Chief Financial Officer |
Exhibit 10.1

October 28, 2025
VIA EMAIL
Yorkville Advisors Global, LP
1012 Springfield Avenue
Mountainside, New Jersey 07092
Attention: David Fine, Esq.
Re: MSP Recovery, Inc. Floor Price Adjustment
Dear Mr. Fine:
Reference is made to the Exchangeable Promissory Notes (“Notes”) issued pursuant to the Standby Equity Purchase Agreement dated November 14, 2023 by and between YA II PN, Ltd. (“Yorkville”) and MSP Recovery, Inc. (“MSP Recovery”).
This letter serves as written notice by MSP Recovery to Yorkville that, effective as of the date hereof, the Floor Price, as defined in paragraph (12)(t) of the Notes, shall be reduced from $1.00 to $0.50 per share.
Sincerely,
_______________________
Name: John H. Ruiz
Title: Chief Executive Officer
Acknowledged and agreed:
YA II PN, Ltd.
By: Yorkville Advisors Global, LP
Its: Investment Manager
By: Yorkville Advisors Global II, LLC
Its: General Partner
By:
_______________________
Name: Matthew Beckman
Title: Member
Page 1 of NUMPAGES 2
Exhibit 10.2
THIS PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE. NEITHER THIS PROMISSORY NOTE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION.
MSP RECOVERY, INC.
Amended and Restated Promissory Note
|
|
Issuance Date: October 24, 2025 |
Principal Amount: $35,359,470.31 |
WHEREAS, MSP Recovery, Inc. d/b/a LifeWallet, a Delaware corporation (formerly known as Lionheart Acquisition Holdings II, the “Company”) and Nomura Securities International, Inc. (together with its permitted successors and assigns, “Holder”) are the issuer and holder respectively of that certain amended and restated promissory note, issued by the Company in an original principal amount of $33,564,480.81 on June 26, 2025, with a maturity date of November 30, 2026 (the “Existing Promissory Note”); and
WHEREAS, the Company has requested to amend the terms of the Existing Promissory Note and Lender has agreed to do so on the terms set forth in this amended and restated promissory note (the “Promissory Note”).
FOR VALUE RECEIVED, the Company hereby promises to pay to the Holder the principal amount of $35,359,470.31 (representing the original principal, capitalized interest and accrued and unpaid interest on the Existing Promissory Note, and as may be reduced pursuant to Section 1(b), Section 4(d) or increased pursuant to Section 2, the “Principal Amount”) when due (whether on the Maturity Date, pursuant to acceleration or otherwise) and to pay interest at the rates and times as set forth in this Promissory Note. The Company acknowledges that such amounts shall be due and payable on November 30, 2026 (the “Maturity Date”).
2
3
4
5
6
7
Miguel Espinosa
Head of Americas Investment Banking
Facsimile: (646) 587-9706
Email: [email protected]
Karthik Venkatesh
COO, Americas Investment Banking
Facsimile: (646) 587-9511
Email: [email protected]
James Chenard
Head of Americas Equity Capital Markets and Solutions
Facsimile: (646) 587-8740
Email: [email protected]
Meir Lewis
Head of Americas Financial Institutions
Email: [email protected]
Oliver Trumbo
Head of IBD Legal – Americas
Facsimile: (646) 587-9548
Email: [email protected]
And to the Company at:
8
MSP Recovery, Inc.
Attn: Alexandra Plasencia
2701 S. Le Jeune Rd, Floor 10
Coral Gables, Florida 33146
9
10
11
12
[signature page follows]
13
IN WITNESS WHEREOF, the Company has caused this Promissory Note to be duly executed as of the Issuance Date set out above, intending to create an instrument executed under seal.
MSP Recovery, Inc.
|
By: |
Name: |
Title: |
Signature Page to MSP A&R Promissory Note
4913-8242-7762 v.5
ACKNOWLEDGED AND AGREED TO BY:
NOMURA SECURITIES INTERNATIONAL, INC.
By: __________________________
Name: James Chenard
Title: Managing Director
Signature Page to MSP A&R Promissory Note
4913-8242-7762 v.5
Exhibit 10.5
NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS EXCHANGEABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.
Lionheart II Holdings, LLC
Exchangeable Promissory Note
Original Principal Amount: $500,000 |
Issuance Date: October 28, 2025
Number: MSPR-9
FOR VALUE RECEIVED, Lionheart II Holdings, LLC, an entity organized under the laws of the State of Delaware (the “Company”), hereby promises to pay to the order of YA II PN, LTD., or its registered assigns (the “Holder”), the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to repayment, redemption, conversion or otherwise, the “Principal”) and Redemption Premium, as applicable, in each case when due, and to pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate (as defined below) from the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether upon the Maturity Date or acceleration, exchange, redemption or otherwise (in each case in accordance with the terms hereof). Certain capitalized terms used herein are defined in Section (12). The Issuance Date is the date of the first issuance of this Exchangeable Promissory Note (the “Note”) regardless of the number of transfers and regardless of the number of instruments, which may be issued to evidence such Note. This Note was issued with a 10% original issue discount.
This Note is being issued pursuant to Section 2.01 of the Standby Equity Purchase Agreement, dated November 14, 2023 (as supplement by the supplemental agreement on June 26, 2025 (the “Supplemental Agreement”), and as further supplement by the second supplemental agreement on October 10, 2025, (the “Second Supplemental Agreement”), and as may be amended, amended and restated, extended, supplemented or otherwise modified in writing from time to time, the “SEPA”), between MSP Recovery, Inc. (“Parent”) and the YA II PN, Ltd., as the Investor (as supplemented by the Second Supplemental agreement dated October 10, 2025 (the “Second Supplemental Agreement”). This Note may be repaid in accordance with the terms of the SEPA, including, without limitation, pursuant to Investor Notices and corresponding Advance Notices (as defined in the SEPA) deemed given by the Parent in connection with such Investor
Notices (as defined in the SEPA). The Holder also has the option of exchanging on one or more occasions all or part of the then outstanding balance under this Note by delivering to the Company one or more Exchange Notices in accordance with Section 3 of this Note.
2
3
4
5
6
7
8
9
10
If to the Company, to: |
MSP Recovery, Inc. |
|
3150 SW 38th Avenue, Suite 1100 |
|
Attn: John Ruiz, CEO Frank Quesada, CLO |
|
E-mail: [email protected], [email protected] |
|
|
|
|
If to the Holder: |
YA II PN, Ltd |
|
c/o Yorkville Advisors Global, LLC 1012 Springfield Avenue |
|
Mountainside, NJ 07092 |
|
Attention: Mark Angelo |
|
Telephone: 201-985-8300 |
|
Email: [email protected] |
or at such other address and/or email and/or to the attention of such other person as the recipient party has specified by written notice given to each other party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice, consent, waiver or other communication, (ii) electronically generated by the sender's email service provider containing the time, date, recipient email address or (iii) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by
11
facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.
12
13
14
15
16
17
[Signature Page Follows]
18
IN WITNESS WHEREOF, the Company and the Parent have caused this Exchangeable Promissory Note to be duly executed by a duly authorized officer as of the date set forth above.
|
COMPANY: |
|
LIONHEART II HOLDINGS, LLC |
|
|
|
By: |
|
Name: John H. Ruiz |
|
Title: Authorized Representative |
|
|
|
|
|
|
|
PARENT: |
|
MSP RECOVERY, INC. |
|
|
|
By: |
|
Name: John H. Ruiz |
|
Title: CEO |
EXHIBIT I
EXCHANGE NOTICE
(To be executed by the Holder in order to Exchange the Note)
TO: LIONHEART II HOLDINGS, LLC
Via Email:
The undersigned hereby irrevocably elects to exchange a portion of the outstanding and unpaid Exchange Amount of Note No. MSPR-9 into Common Shares of MSP RECOVERY, INC., according to the conditions stated therein, as of the Exchange Date written below.
|
|
|
Exchange Date: |
|
|
Principal Amount to be Exchanged: |
|
|
Accrued Interest to be Exchanged: |
|
|
Total Exchange Amount to be Exchanged: |
|
|
Fixed Price: |
|
|
Variable Price: |
|
|
Applicable Exchange Price: |
|
|
Number of Common Shares to be issued: |
|
|
|
|
|
Please issue the Common Shares in the following name and deliver them to the following account: |
||
Issue to: |
|
|
Broker DTC Participant Code: |
|
|
Account Number: |
|
|
|
|
|
Authorized Signature: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|